BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2023 Earnings Call Transcript

Page 6 of 6

Alexander Hardy: Thank you very much for joining us today. As you’ve heard, we are really hard at work here on shaping the future corporate and R&D strategy, as well as setting ambitious long-term financial goals. As you’ve heard, these are on about accelerating revenue and also profitability. We’re approaching this work with a sense of urgency, and we’re making significant progress. We’re looking forward to sharing that with you on a timely basis. So as you heard, please stay tuned for additional updates. Thank you very much for your attention and your questions, and good-bye.

Operator: This concludes today’s call. You may now disconnect.

Follow Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

Page 6 of 6